Related Experiment Video
Updated: Dec 4, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Matrix Metalloprotease-7 Mediates Nucleolar Assembly and Intra-nucleolar Cleaving p53 in Gefitinib-Resistant Cancer
Wei-Hsuan Yu1,2, Erxi Wu3,4,5, Yongqing Li6
1Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei 10051, Taiwan.
Abstract:
The enlarged distinct bulky-ball-like nucleolus matrix assembly is observed in most cancer stem cells (CSCs); however, the underlying mechanism is largely unknown. We show that matrix metalloproteinase-7 (MMP-7) shedding MUC-1 SEA domain releases MUC-1 C-ter, facilitating the nucleolus trafficking of p53 in gefitinib-resistant lung CSCs. The nucleolus colocalizations of p53, MUC-1 C-ter, MMP-7 and nucleolin were observed in the CD34+ CXADR+ CD44v3 + gefitinib-resistant EGFRL858R/T790M CSC colonies. MUC-1 C-ter induced a unique porous bulky-ball-shaped, cagelike nucleolus that functions as a nucleus molecular "garage" for potent tumor suppressor, p53. Nucleolus could also facilitate the novel sub-nucleus compartment for proteolytic processing p53 by MMP-7 to generate a 35 kDa fragment. Moreover, we show that salinomycin, an anti-CSC agent, disrupts nucleolus by inducing nucleoplasm translocation of p53 and sensitizing CSC to chemotherapy drugs. Thus, this study highlights the MMP-7-MUC-1-p53 axis in nucleolus as a potential therapeutic target for anti-CSCs to resolve the chemotherapy-resistance dilemma.
Insights
Matrix metalloproteinase-7 (MMP-7) and MUC-1 C-ter facilitate p53 transport to the nucleolus in cancer stem cells (CSCs). Targeting this MMP-7-MUC-1-p53 axis may overcome chemotherapy resistance in CSCs.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Cancer stem cells (CSCs) often exhibit enlarged nucleoli, but the mechanisms remain unclear.
- Gefitinib-resistant lung CSCs present a significant challenge in cancer therapy.
- The role of nucleolar structure in cancer progression and drug resistance is an emerging area of research.
Purpose of the Study:
- To elucidate the mechanism behind the enlarged nucleolus in cancer stem cells.
- To investigate the role of matrix metalloproteinase-7 (MMP-7) and MUC-1 in nucleolar function and p53 trafficking.
- To identify potential therapeutic targets for overcoming chemotherapy resistance in CSCs.
Main Methods:
- Analysis of nucleolus matrix assembly in cancer stem cells.
- Investigating the interaction between MMP-7, MUC-1 C-ter, and p53 using immunofluorescence and cell biology techniques.
- Assessing the effect of salinomycin on nucleolar structure and p53 localization in CSCs.
Main Results:
- MMP-7 shedding of MUC-1 SEA domain releases MUC-1 C-ter, promoting p53 nucleolar trafficking in resistant CSCs.
- A unique, bulky-ball-shaped nucleolus acts as a "garage" for p53 and facilitates its processing by MMP-7.
- Salinomycin disrupts the nucleolus, causing p53 translocation and sensitizing CSCs to chemotherapy.
Conclusions:
- The MMP-7-MUC-1-p53 axis within the nucleolus is crucial for CSC survival and chemoresistance.
- Targeting this nucleolar pathway offers a potential strategy to overcome chemotherapy resistance.
- Disruption of nucleolar function presents a novel therapeutic approach against cancer stem cells.
More Related Videos
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
Mitogens and the Cell Cycle
The Nucleolus
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...